Efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type II diabetes
<h3>Background:</h3><p dir="ltr">Recent systematic reviews have evaluated the efficacy of sodium-glucose co-transporter 2 inhibitors (SGLT2) inhibitors (SGLT2I) in improving glycaemic control and mortality in patients with type II diabetes mellitus. None have incorporated...
محفوظ في:
| المؤلف الرئيسي: | Mohammed Ibn-Mas’ud Danjuma (13192169) (author) |
|---|---|
| مؤلفون آخرون: | Shaikha Al Shokri (18131404) (author), Arwa Ibrahim YA Al Saud (18147574) (author), Mohamed Nabil Abdelsalam Elshafei (18147577) (author), Haajra Fatima (9376835) (author), Suhail Doi (2827514) (author), Mubarak Ariyo Bidmos (9376850) (author) |
| منشور في: |
2019
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country
حسب: Nancy Zaghloul (14147865)
منشور في: (2022) -
Evaluating the appropriateness and the factors associated with sodium-glucose co-transporter 2 inhibitors prescribing in a Middle Eastern country: a cross-sectional study
حسب: Nancy Zaghloul (14147865)
منشور في: (2024) -
A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
حسب: Alaa Rahhal (14150403)
منشور في: (2022) -
Molybdenum‐Incorporated O3‐type Sodium Layered Oxide Cathodes for High‐Performance Sodium‐Ion Batteries
حسب: Buzaina Moossa (17337883)
منشور في: (2023) -
Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension
حسب: Yousef, Hibba
منشور في: (2023)